Resolute Advisors’s Pfizer PFE Stock Holding History

Resolute Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,308	Closed	-$56K	–	435
2021 Q3	$56K	Hold	1,308	–	–	0.01%	110
2021 Q2	$51K	Hold	1,308	–	–	0.01%	82
2021 Q1	$36K	Buy	+1,308	New	+$46.4K	﹤0.01%	96

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Resolute Advisors's PFE Position: Q4 2021 in Review

Resolute Advisors sold out of Pfizer (PFE) in Q4 2021, closing a stake of 1,308 shares — an estimated $56K sold.

Resolute Advisors first reported a position in PFE in Q1 2021 and held it in 3 quarters. The position peaked at $56K in Q3 2021. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

Resolute Advisors reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 1,308 Pfizer shares in Q4 2021, an estimated $56K.
Resolute Advisors first reported a position in Pfizer in Q1 2021 and held it in 3 quarters.
Resolute Advisors's Pfizer position peaked at $56K in Q3 2021.
3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.